Class II · Moderate risk
Vancomycin Hydrochloride Capsules
Subpotent Drug
FDA Drug Recalls
1,464 recalls · Class II, newest first
Class II · Moderate risk
Vancomycin Hydrochloride Capsules
Subpotent Drug
Class II · Moderate risk
Mafenide Acetate
Presence of Foreign Substance; oxidized steel, organic material and shredded polypropylene
Class II · Moderate risk
Dextroamphetamine Sulfate Extended-Release Capsules
Failed Dissolution Specifications
Class II · Moderate risk
Antacid Liquid Regular Strength Antacid & Anti-Gas
Microbial Contamination of Non-Sterile Products: Lots failed microbiological testing at the 12-month time point.
Class II · Moderate risk
Erythromycin Pledgets USP
Microbial Contamination of Non-Sterile Products: Active Pharmaceutical Ingredient (API) failed USP microbial tests.
Class II · Moderate risk
Compounded Plaquex
Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.
Class II · Moderate risk
KETOROLAC Tromethamine Inj.
Crystallization
Class II · Moderate risk
KETOROLAC Tromethamine Inj.
Crystallization
Class II · Moderate risk
Ketorolac Tromethamine Ophthalmic Solution
Presence of Particulate Matter: lot is not meeting the specification limit for number of particles present in the solution.
Class II · Moderate risk
Levetiracetam
Failed Dissolution Specifications: 6 month time point.
Class II · Moderate risk
Daytrana (methylphenidate transdermal system)
Defective Delivery System: One lot exceeded the mechanical peel specification
Class II · Moderate risk
Benzonatate Capsules
Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules
Class II · Moderate risk
Glycopyrrolate injection
Labeling: Incorrect or missing Lot and/or Exp Date: Printing error caused an overlap in the "y" and "3" making the actual "Use By 3/2015" date appear to read "Use By8/2015".